A detailed history of Hexagon Capital Partners LLC transactions in Amgen Inc stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 2,732 shares of AMGN stock, worth $877,873. This represents 0.17% of its overall portfolio holdings.

Number of Shares
2,732
Previous 2,862 4.54%
Holding current value
$877,873
Previous $894,000 1.57%
% of portfolio
0.17%
Previous 0.2%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$309.38 - $337.38 $40,219 - $43,859
-130 Reduced 4.54%
2,732 $880,000
Q2 2024

Jul 12, 2024

BUY
$262.75 - $319.31 $22,596 - $27,460
86 Added 3.1%
2,862 $894,000
Q1 2024

Apr 18, 2024

SELL
$268.87 - $324.56 $88,189 - $106,455
-328 Reduced 10.57%
2,776 $789,000
Q4 2023

Feb 05, 2024

BUY
$255.7 - $288.46 $25,570 - $28,845
100 Added 3.33%
3,104 $894,000
Q3 2023

Oct 23, 2023

BUY
$218.65 - $271.46 $32,578 - $40,447
149 Added 5.22%
3,004 $807,000
Q2 2023

Jul 24, 2023

BUY
$214.27 - $253.37 $2,356 - $2,787
11 Added 0.39%
2,855 $633,000
Q1 2023

Apr 24, 2023

BUY
$225.79 - $275.2 $30,481 - $37,152
135 Added 4.98%
2,844 $687,000
Q4 2022

Jan 13, 2023

SELL
$229.03 - $291.01 $68,479 - $87,011
-299 Reduced 9.94%
2,709 $0
Q3 2022

Oct 17, 2022

BUY
$224.46 - $253.15 $83,050 - $93,665
370 Added 14.03%
3,008 $678,000
Q2 2022

Jul 21, 2022

SELL
$230.71 - $256.74 $38,528 - $42,875
-167 Reduced 5.95%
2,638 $642,000
Q1 2022

Apr 13, 2022

BUY
$219.27 - $242.57 $19,295 - $21,346
88 Added 3.24%
2,805 $678,000
Q4 2021

Jan 27, 2022

BUY
$198.88 - $227.6 $45,742 - $52,348
230 Added 9.25%
2,717 $611,000
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $119,932 - $140,515
565 Added 29.4%
2,487 $529,000
Q2 2021

Aug 11, 2021

BUY
$233.58 - $259.14 $45,080 - $50,014
193 Added 11.16%
1,922 $468,000
Q1 2021

May 13, 2021

SELL
$221.91 - $258.6 $1,775 - $2,068
-8 Reduced 0.46%
1,729 $430,000
Q3 2020

Nov 10, 2020

BUY
$234.65 - $260.95 $407,587 - $453,270
1,737 New
1,737 $382,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Hexagon Capital Partners LLC Portfolio

Follow Hexagon Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.